Novaremed AG

About:

Novaremed AG is a clinical-stage Swiss biopharmaceutical company.

Website: http://www.novaremed.com/

Top Investors: The Global Emerging Markets Group

Description:

Novaremed AG is a clinical-stage Swiss biopharmaceutical company.

Total Funding Amount:

$52.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2017-01-01

Founders:

Eli Kaplan

Number of Employees:

1-10

Last Funding Date:

2021-02-04

IPO Status:

Private

Industries: